page_banner

product

N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine CAS NO. 231278-20-9

Short Description:

Product Name:N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine

CAS NO.:231278-20-9

Synonyms:6-Iodo-4-[3-chloro-4-(3-fluorobenzyloxy)anilino]quinazoline;

4-[3-Chloro-4-(3-fluorobenzyloxy)phenylamino]-6-iodoquinazolin;

lapatinib intermediate

Related Categories:Intermediates; anti-cancer; lapatinib ditosylate intermediate;

anticancer drug lapatinib intermediate; pharmaceutical intermediate; chemical intermediate ;

 

 

 

 


Product Detail

Product Tags

Product Information

Name N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine
CAS NO. 231278-20-9
Molecular Formula C21H14ClFIN3O Molecular Weight 505.71
MDL No. MFCD09998827 EINECS 607-200-2
M.P. 222-224°C B.P. 581.3±50.0 °C(Predicted)
Density 1.691±0.06 g/cm3(Predicted) Refractive Index N.A.

F.P.

N.A.

Storage condition

Keep in dark place,

Inert atmosphere,Room temperature

 
Appearance yellow to dark yellow solid
Purity 98%
Application anticancer drug lapatinib intermediate

Supply Ability

N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine CAS NO.231278-20-9 is our regularly production product, whether you need small sample or a large cargo of more than tonnage, our company can supply it formally

 

Contact Information

If you are interested in N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine CAS NO.231278-20-9, feel freely contact us please, and we will provide you the best quality products, reasonable price and best service, expecting to our cooperation.

E-Mail

info@leichi-chem.com

charleen@leichi-chem.com

Phone No.

+86 139 6251 3054

+86 136 2174 3828

The products listed by the company involve patents, which are only for research and development and not for sale; controlled products will be sold in strict compliance with Chinese laws and the laws of the country where they are purchased, and all products are not suitable for human use. If sold, they will constitute patent infringement country, all corresponding risks will be borne by the buyer.


  • Previous:
  • Next:

  • Write your message here and send it to us